Short Interest Declines 47.4% For RGEN

The most recent short interest data has been released by the NASDAQ for the 12/13/2013 settlement date, which shows a 2,703,495 share decrease in total short interest for Repligen Corp. ( RGEN), to 3,000,100, a decrease of 47.40% since 11/29/2013. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for RGEN at the 12/13/2013 settlement increased to 457,422, as compared to 382,643 at the 11/29/2013 report. That brought "days to cover" down to 6.56, a 56.00% decrease from the 14.91 days to cover calculated at the previous short interest data release.

Top 25 S.A.F.E. Dividend Stocks »

The below chart shows the historical "days to cover" for RGEN at previous short interest release dates:

A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where RGEN had been shorted as a hedge.

The chart below shows the one year performance of RGEN shares, versus its 200 day moving average. Looking at this chart, RGEN's low point in its 52 week range is $5.73 per share, with $14.05 as the 52 week high point — that compares with a last trade of $12.83.

If you liked this article you might like

Drug Stocks Find Trump Animus a Bitter Pill

5 Health Care Stocks Set to Bounce

Repligen Has More Upside Ahead

Repligen Has More Upside Ahead

Trade-Ideas: Repligen (RGEN) Is Today's Weak On High Relative Volume Stock

Today's Dead Cat Bounce Stock Is Repligen (RGEN)